Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Voyager Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2015 Thoroughbred

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$60M
Market cap · Apr/2026
Revenue
$40M
Latest reported FY

Investors

7 investors on Voyager Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Global footprint

Where Voyager Therapeutics has talent and traffic

AI talent share
3.0% of workforce is AI talent
(5 of 168 staff)
Core AI10.6%
Other AI42.38%
Non-AI workforce16397.02%
Web traffic by country
7.5K monthly visits
across markets
🇺🇸 United States77.3%
🇮🇳 India12%
🇫🇷 France8%
🏳️ Korea2.7%
🏳️ Republic of0%
Top 5 markets shown

See Voyager Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.